Pressure injuRy preventiOn by inTermittent EleCtrical sTimulation
NCT ID: NCT04328246
Last Updated: 2023-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
4 participants
INTERVENTIONAL
2021-02-26
2022-03-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The PROTECT 2 Study : Pressure Injury Treatment by Intermittent Electrical Stimulation: A Randomized, Controlled Trial
NCT05085288
Implanted Gluteal Stimulation System for Pressure Sore Prevention
NCT00623948
Validation and Usability Study of Intermittent Electrical Simulation in Management of Pressure Injuries Stages 1 and 2
NCT06435143
Transcutaneous and Epidural Stimulation in SCI
NCT04627441
Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation
NCT04207723
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IES Device + Standard of Care
Intermittent electrical stimulation system. Charged pulses will be administered to bilateral gluteus maximus through surface electrodes. Stimulation occurs at 30 Hz for 10s every 10 minutes. The intervention is administered 24/7 and added to the standard of care management. Standard of care is defined as turning the patient every two hours.
IES System
The IES system is composed of a stimulator and self-adhesive surface gel electrodes.
Standard of Care Therapy
Standard institutional practices for treating pressure injury.
Standard of Care
Standard of care treatment for pressure injuries is turning the patient every two hours.
Standard of Care Therapy
Standard institutional practices for treating pressure injury.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IES System
The IES system is composed of a stimulator and self-adhesive surface gel electrodes.
Standard of Care Therapy
Standard institutional practices for treating pressure injury.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Braden Scale score (Ranges from 6 to 23)
* 1 for Low Serum Albumin
* 1 for Type II Diabetes
2. Anticipated length of stay of at least 4 days
3. BMI \< 35
4. Participants capable of giving informed consent, or if appropriate, participants having an acceptable individual capable of giving consent on the participant's behalf.
Exclusion Criteria
2. Neuromuscular blocking drugs \& myasthenia gravis: may prevent the ability of electrical stimulation to induce muscular contraction
3. Unstable spinal, pelvic, or hip fractures that may be displaced by a forced contraction
4. Rhabdomyolysis
5. Use of a Pacemaker
6. Skin breakdown over the gluteal regions that would preclude the use of surface electrodes.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rehabtronics
UNKNOWN
AHS Cancer Control Alberta
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cross Cancer Institute
Edmonton, Alberta, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIT-0018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.